Premium
Co‐expression of LAG 3 and TIM 3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients
Author(s) -
Ma Qiang,
Liu Junning,
Wu Guoliang,
Teng Mujian,
Wang Shaoxuan,
Cui Meng,
Li Yuantao
Publication year - 2018
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/1440-1681.12992
Subject(s) - il 2 receptor , foxp3 , cd86 , cytotoxic t cell , cancer research , tumor necrosis factor alpha , immunology , microbiology and biotechnology , biology , t cell , chemistry , immune system , in vitro , biochemistry
Summary Regulatory T (Treg) cells are critical suppressors of inflammation and are thought to exert mainly deleterious effects in cancers. In colorectal cancer ( CRC ), Foxp3 + Treg accumulation in tumors was associated with poor prognosis. Hence, we examined the circulating Treg cells in CRC patients. Compared to controls, CRC patients presented mild upregulations in CD 4 + CD 25 +/hi T cells and in the more canonical CD 4 + CD 25 +/hi Foxp3 + Treg cells in peripheral blood mononuclear cells. Both of these Treg populations could be roughly divided into lymphocyte activation gene 3 negative T cell immunoglobulin and mucin‐domain containing‐3 negative ( LAG 3 − TIM 3 − ) and LAG 3 + TIM 3 + subsets. In CRC patients, the LAG 3 + TIM 3 + subset represented approximately half of CD 4 + CD 25 +/hi T cells and greater than 60% of CD 4 + CD 25 +/hi Foxp3 + Treg cells, which was significantly more frequent than in healthy controls. Compared to the LAG 3 − TIM 3 − CD 4 + CD 25 +/hi T cells, the LAG 3 + TIM 3 + CD 4 + CD 25 +/hi T cells presented considerably higher transforming growth factor‐β and slightly higher interleukin ( IL )‐10 secretion, together with higher cytotoxic T‐lymphocyte associated protein 4 and Foxp3 expression levels. Notably, macrophages following incubation with LAG 3 − TIM 3 − CD 4 + CD 25 +/hi T cells and LAG 3 + TIM 3 + CD 4 + CD 25 +/hi T cells displayed different characteristics. Macrophages incubated with LAG 3 + TIM 3 + CD 4 + CD 25 +/hi T cells presented lower expression of major histocompatibility complex class II , CD 80, CD 86, and tumor necrosis factor‐α but higher expression of IL ‐10, than macrophages incubated with LAG 3 − TIM 3 − CD 4 + CD 25 +/hi T cells. Together, our investigations demonstrated that CRC patients presented an enrichment of circulating Treg cells, in which the LAG 3 + TIM 3 + subset exhibited more potent expression of inhibitory molecules, and furthermore, the LAG 3 + TIM 3 + Treg cells could suppress the proinflammatory activation of macrophages more potently than the LAG 3 − TIM 3 − Treg cells.